Answers are grounded in this paper and cite their sources.
T-segment-elevation myocardial infarction (STEMI) is a leading cause of death worldwide, 1 and immediate reperfusion can be life-saving. 2 Although primary percutaneous coronary intervention (PCI) is the most effective modality for achieving reperfusion in STEMI, 2,3 the benefit of primary PCI over thrombolytics on survival is time-dependent. Prior studies have showed that the survival benefit of primary PCI over thrombolytics may be negated if PCI-related delay exceeds by >60 minutes. Accordingly, national quality improvement initiatives during the past decade have focused on reducing delays in primary PCI, especially in patients who present directly to a PCI-capable hospital.
No takes yet. Share an insight, caveat, or question.
Mentias et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: